Institutional

<p>News and Publications of Kasznar Leonardos Intelectual Property, with Offices in RJ, SP and RS – Brazil.</p>

Published ANVISA’s new rule relative to the prior consent for the granting of a patent for pharmaceutical products and processes

On August 8 2017 ANVISA officially published the new Rule RDC Nº 168, related to the prior consent of the Agency on patent applications for pharmaceutical products and processes, regulated by Joint Ordinance ANVISA-INPI No. 1, dated April 12, 2017, aiming to a more efficient way to analyze patent applications.

Medical Devices – ANVISA´s Public Consultation to extend the registration term

ANVISA has published, on 08/02/2017, in the Federal Register, the the Public Consultation 371/2017 to discuss the extension, from 5 to 10 Medical Devices – ANVISA´s Public Consultation to extend the registration term

The Ministry of Industry and Commerce and the Brazilian Patent and Trademark Office launch a Public Consultation on a Proposal for dealing with the Patent Applications’ backlog

The Ministry of Industry and Commerce (MDIC) and the Brazilian Patent and Trademark Office (INPI) have opened for Public Consultation a Proposal for a Resolution to regulate a simplified allowance procedure for patent applications in Brazil, aiming to deal in a swift manner with the ever increasing backlog of patent applications awaiting examination, currently exceeding the figure of 230.000.

Opened for Public Consultation a Proposal for a Resolution to regulate a simplified allowance procedure for patent applications in Brazil

The Ministry of Industry and Commerce (MDIC) and the Brazilian Patent and Trademark Office (INPI) have opened for Public Consultation a Proposal for a Resolution to regulate a simplified allowance procedure for patent applications in Brazil, aiming to deal in a swift manner with the ever increasing backlog of patent applications awaiting examination, currently exceeding the figure of 230.000.

São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending

Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending

3D Printing – ANVISA orders shutdown of production line of customized prostheses

ANVISA has informed in its website, on 07/04/2017, the undertake of an operation that determined the shutdown, for at least 30 days, of a manufacturing line of personalized face and skull prostheses.
According to ANVISA, the Senai Joinville (a branch of the National Industrial Apprentice Service) has been manufacturing customized prostheses without authorization of the regulatory agency.

 

IAM Patent 1000 classifies Kasznar Leonardos among the leadind firms

This is the sixth edition of the IAM Patent 1000 – The World's Leading Patent Professionals, a guide that identifies leading firms and patent professionals around the world. Kasznar Leonardos is once again ranked in the gold category of the guide, positioning itself among the market leaders.

Kasznar Leonardos announces new partner

With the aim of expanding the office's operations and reinforcing its growth strategy, we announce the arrival of the lawyer Fernanda Magalhães, who will lead an important area for the development of KL: Marketing & Entertainment Law.

Kasznar Leonardos stands out in 8 categories of the Leaders League ranking

Kasznar Leonardos was featured in the ranking Innovation – Technology and Intellectual Property 2017, released by the Leaders League. The firm was classified in 8 categories, having 11 partners mentioned in the publication. 

Kasznar Leonardos remains “Gold” in the World Trademark Review 1000 – 2017

The guide, which is already in its 7th edition, identifies and highlights, through qualitative research, the firms and leading trademark experts in 72 jurisdictions.